Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis
Background Liver fibrosis is often a consequence of chronic liver injury, and has the potential to progress to cirrhosis and liver cancer. Despite being an important human disease, there are currently no approved anti-fibrotic drugs. In this study, we aim to identify the key genes and pathways gover...
Main Authors: | Zhu Zhan, Yuhe Chen, Yuanqin Duan, Lin Li, Kenley Mew, Peng Hu, Hong Ren, Mingli Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2019-03-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/6645.pdf |
Similar Items
-
Bioinformatics microarray analysis and identification of gene expression profiles associated with cirrhotic liver
by: Kun-Ming Chan, et al.
Published: (2016-04-01) -
Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma
by: Chen Hao Jiang, et al.
Published: (2020-01-01) -
New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article
by: Hedyeh Ebrahimi, et al.
Published: (2018-07-01) -
Pathogenesis and new therapeutic targets of liver fibrosis
by: ZHANG Wei, et al.
Published: (2017-03-01) -
Recent research on liver fibrosis and cirrhosis
by: LU Lungen
Published: (2013-05-01)